Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Marco Spartera



  • Graduate reading for D.Phil. in Medical Sciences - Cardiovascular Medicine
  • Specialist in Cardiology
  • NIHR Oxford Biomedical Research Centre Clinical Research Fellow - Multi-Imaging Modalities in Cardiovascular Medicine

I am a cardiologist specialized in non-invasive cardiac imaging with a particular focus on cardiovascular MRI, CT, and echocardiography. My medical degree (2011) and my cardiology specialist degree (2017) were both awarded with first class honours at the San Raffaele University, Milan, Italy.

I am currently a graduate reading for D.Phil. in Medical Sciences, working at the Centre for Magnetic Resonance Research (OCMR) - University of Oxford - Radcliffe Department of Medicine, under the supervision of Prof. Barbara Casadei and Prof. Stefan Neubauer.

My doctoral research, funded by NIHR Oxford Biomedical Research Centre, is focused on developing imaging biomarkers of cardioembolic & stroke risk. Stroke is a major health condition with an incidence of at least 100,000 per year in the United Kingdom, and a 30-day mortality of approximately 23%. Of those who survive stroke, approximately 50% suffer from disability, and around 1 in 4 will experience another stroke within five years. 

Finally, I have been running a Randomized Clinical Trial to investigate whether in older overweight/obese patients with Atrial Fibrillation (AF) weight loss can improve AF and improve physical performance as compared to usual care. LOSE-AF Trial (NCT03713775) is currently recruiting at Oxford University Hospital NHSFT, Milton Keynes University Hospital NHSFT, and Royal Berkshire Hospital NHSFT. Atrial fibrillation (AF) affects over 1 million individuals in the UK and results in costs of over £450 million per year to the National Health Service (NHS). Current rhythm control strategies are limited by high recurrences of AF. New strategies tackling more upstream pathophysiological mechanisms are most needed. The incidence and prevalence of AF markedly increase with age, whilst obesity is the strongest modifiable risk factor for AF. 

Key publications

Recent publications

More publications

Recent publications

M Spartera, F Ancona, M Barletta, I Rosa, S Stella, C Marini, L Italia, M Montorfano, A Latib, O Alfieri, A Margonato, A Colombo, E Agricola. Echocardiographic signs of post-TAVI thrombosis and endocarditis. Echocardiography. 2017 Dec 21.

M Spartera, A Damascelli, F Mozes, F De Cobelli, G La Canna. Three-dimensional speckle tracking longitudinal strain is related to myocardial fibrosis determined by late-gadolinium enhancement. Int J Cardiovasc Imaging 2017.

M Spartera, R Jabbour, M De Bonis, F Pappalardo. Stepwise use of circulatory support devices in a patient refractory to cardiopulmonary resuscitation. Cardiovasc Revasc Med. 2017 Apr 8;S1553-8389(17)30116-1.

 M Spartera, C Godino, E Baldissera, C Campochiaro, K La Spina, P Aiello, A Salerno, M Cera, V Magni, R J Jabbour, L Dagna, M Tresoldi, A Cappelletti, O Alfieri, A Colombo, M G Sabbadini, A Margonato. Long-term Clinical Outcomes of Patients with Rheumatoid Arthritis and Concomitant Coronary Artery Disease. Am J Cardiovasc Dis. 2017 Feb 15;7(1):9-18.

 M Spartera, M Galderisi D Mele, M Cameli, A D'Andrea, A Rossi, S Mondillo, G Novo, R Esposito, F D'Ascenzi, R Montisci, S Gallina, A Margonato, E Agricola on behalf of the Echocardiographic Study Group of the Italian Society of Cardiology (SIC).  Role of cardiac dyssynchrony and resynchronization therapy in functional mitral regurgitation. Eur Heart J Cardiovasc Imaging 2016 May;17(5):471-80.

 M Spartera, M Schiavo Lena, Sanvito F, Colombo A. Early degeneration and endocarditis in a transcatheter heart valve. Eur Heart Journal 2016 Jul 21;37(28):2289.

 M Spartera, Ottavio Alfieri, Giovanni La Canna. Transient severe tricuspid regurgitation during atrioventricular block. J Echocardiogr 2016 Jun;14(2):87-8.

 E Agricola, F Ancona, S Stella, I Rosa, C Marini, M Spartera, A Margonato, A Colombo, A Latib The use of Echocardiography for Guiding Percutaneous Tricuspid Valve Procedures. JACC Cardiovascular Imaging 2017 (accepted for publication - JIMG031316-0343R1)

 F Giannini; A Aurelio; M Spartera, Azeem Latib; Antonio Colombo. Coronary sinus reducer implantation for the treatment of chronic refractory angina: a single center experience. J Am Coll Cardiol. 2016; 68:B144-B144.

 I Rosa, C Marini, S Stella, F Ancona, M Spartera, A Margonato, E Agricola. Mechanical dyssynchrony and deformation imaging in patients with functional mitral regurgitation. World J Cardiol 2016 February 26; 8(2): 146-162.

 Rutten B, Maseri A, Cianflone D, Laricchia A, Cristell NA, Durante A, M Spartera, Ancona F, Limite L, Hu D, Li H, Uren NG, de Groot PG, Mannucci PM, Roest M. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: A multicenter and multiethnic study. Eur Heart J Acute Cardiovasc Care 2015 Feb; 4(1):64-74.

 Godino C, Parenti DZ, Regazzoli D, Rutigliano D, Lucisano L, Viani GM, M Spartera, Chieffo A, Donahue M, Cappelletti A, Locuratolo N, Parisi R, Fattori R, Presbitero P, Margonato A, Briguori C, Sardella G, Colombo A; Italian Nobori Stent ProspectIve REgistry-1 Investigators. One-Year Outcome of Biolimus Eluting Stent with Biodegradable Polymer in all Comers: The Italian Nobori Stent Prospective Registry. Int J Cardiol. 2014 Nov 15;177(1):11-6.

 C Godino, A Pavon, A Mangieri, G Viani, S Galaverna, M Spartera, A Chieffo, A Cappelletti, A Margonato, A Colombo. PlaCor PRT Measurement of Shear-Activated Platelet Aggregate Formation in Stable Patients treated with Single and Dual Antiplatelet Therapy. Platelets. 2014;25(5):337-42.

 Durante A, Peretto G, Laricchia A, Ancona F, M Spartera, Mangieri A, Cianflone D. Role of the Renin-Angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr Pharm Des. 2012;18(7):981-1004